Details for New Drug Application (NDA): 018423
✉ Email this page to a colleague
The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 018423
Tradename: | HIBICLENS |
Applicant: | Molnlycke Hlth |
Ingredient: | chlorhexidine gluconate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018423
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPONGE;TOPICAL | Strength | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Expired US Patents for NDA 018423
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | 3,855,140 | ⤷ Subscribe |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | 3,960,745 | ⤷ Subscribe |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | 3,886,277 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription